Abvc Biopharma (ABVC) Enterprise Value (2010 - 2026)
Abvc Biopharma (ABVC) reported Enterprise Value of $42.6 million for Q2 2026, down 6.1% from $45.39 million a year earlier but up 58.7% from the prior quarter.
Powered by 
Analysis
Abvc Biopharma (ABVC) Enterprise Value (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Abvc Biopharma's Enterprise Value came in at $41.4 million, down 7.3% year-over-year; for FY2025, it came in at $44.27 million, up 500.9% from FY2024.
- Enterprise Value has a five-year compound annual growth rate of -14.3% (FY2020 to FY2025).
- By year, Enterprise Value came in at $7.37 million in FY2024 (+60.5%), $4.59 million in FY2023 (-76.1%), $19.21 million in FY2022 (-79.0%) and $91.41 million in FY2021 (-4.3%).
- Five-year quarterly Enterprise Value spans a low of $3.79 million in Q3 2023 and a high of $91.41 million in Q4 2021.
- Year over year, Enterprise Value gained in seven of the last eight quarters, with growth averaging 250.3%.
- The high point for year-over-year Enterprise Value in five years was Q3 2025 (growth of 831.3%); the low point was Q3 2023 (a decline of 85.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $26.85 million (Q1 2026), $44.27 million (Q4 2025) and $75.72 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Abvc Biopharma | 27.31 Mn | 29.30 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.60 Mn |
| Mar 31, 2026 | 26.85 Mn |
| Dec 31, 2025 | 44.27 Mn |
| Sep 30, 2025 | 75.72 Mn |
| Jun 30, 2025 | 45.39 Mn |
| Mar 31, 2025 | 18.64 Mn |
| Dec 31, 2024 | 7.37 Mn |
| Sep 30, 2024 | 8.13 Mn |
| Jun 30, 2024 | 8.83 Mn |
| Mar 31, 2024 | 13.04 Mn |
| Dec 31, 2023 | 4.59 Mn |
| Sep 30, 2023 | 3.79 Mn |
| Jun 30, 2023 | 17.04 Mn |
| Mar 31, 2023 | 19.37 Mn |
| Dec 31, 2022 | 19.21 Mn |
| Sep 30, 2022 | 26.44 Mn |
| Jun 30, 2022 | 31.10 Mn |
| Mar 31, 2022 | 79.86 Mn |
| Dec 31, 2021 | 91.41 Mn |
| Sep 30, 2021 | 59.70 Mn |
API Access
Abvc Biopharma Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=ABVC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "ABVC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=ABVC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();